MACQUARIE GROUP LTD - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 218 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$574,000
-17.2%
105,367
+2.0%
0.00%0.0%
Q2 2023$693,000
-10.3%
103,312
+18.0%
0.00%0.0%
Q1 2023$773,000
+74.9%
87,531
+51.2%
0.00%0.0%
Q4 2022$442,000
-20.1%
57,876
-24.5%
0.00%0.0%
Q3 2022$553,000
-12.4%
76,672
-1.7%
0.00%0.0%
Q2 2022$631,000
-42.0%
77,995
-0.4%
0.00%0.0%
Q1 2022$1,087,000
-48.2%
78,346
+4.7%
0.00%
-50.0%
Q4 2021$2,099,000
-1.1%
74,800
+19.8%
0.00%0.0%
Q3 2021$2,123,000
-5.6%
62,456
+13.4%
0.00%0.0%
Q2 2021$2,250,000
+10.6%
55,062
+9.0%
0.00%
-33.3%
Q1 2021$2,034,000
-13.3%
50,509
+27.3%
0.00%0.0%
Q4 2020$2,346,000
+12.3%
39,662
-7.7%
0.00%
-25.0%
Q3 2020$2,089,000
-6.4%
42,970
-6.8%
0.00%0.0%
Q2 2020$2,231,000
+90.0%
46,121
+9.2%
0.00%
+100.0%
Q1 2020$1,174,000
+28.4%
42,250
+38.3%
0.00%
+100.0%
Q4 2019$914,00030,5530.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q3 2021
NameSharesValueWeighting ↓
Eagle Health Investments LP 1,014,860$14,086,0003.47%
Triatomic Management LP 297,048$4,123,0003.35%
Diametric Capital, LP 265,000$3,678,0002.03%
Matrix Capital Management Company, LP 11,572,590$160,628,0001.93%
VIKING GLOBAL INVESTORS LP 29,993,708$416,313,0001.68%
TIGER MANAGEMENT L.L.C. 589,311$8,180,0001.35%
Aristotle Atlantic Partners, LLC 759,412$10,541,0000.65%
Casdin Capital, LLC 1,000,000$13,880,0000.62%
Pier Capital, LLC 339,541$4,713,0000.60%
Leeward Financial Partners, LLC 68,504$951,0000.59%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders